News: OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical …
Preclinical data on PSN821, a novel, orally available agonist of the G-protein coupled receptor GPR119, being developed for the treatment of type 2 and obesity, were presented in an oral presentation. Also ...
Treatment for Type 1 Diabetes
Related posts. What causes Diabetes? (0); Hyperglycemia and Type 1 and Type 2 Diabetes (0); General introduction to Diabetes (0); Diabetes and Childhood Obesity (0); Diabetes - Treatment Methods for Diabetes (0)
Treatment for Type 1 Diabetes
Related posts. What causes Diabetes? (0); Hyperglycemia and Type 1 and Type 2 Diabetes (0); General introduction to Diabetes (0); Diabetes and Childhood Obesity (0); Diabetes - Treatment Methods for Diabetes (0)
Original article: News: OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical …
Tags: diabetes, type, obesity, treatment, preclinical
Tags: diabetes, type, obesity, treatment, preclinical